The Next Generation Transit Survey (NGTS)

Autor: Goad Michael, Genolet Ludovic, Erikson Anders, Eigmüller Philipp, Cabrera Juan, Burleigh Matthew, Bento Joao, Bannister Nigel, Walker Simon, Louden Tom M., Chazelas Bruno, West Richard G., Watson Christopher A., Rauer Heike, Queloz Didier, Pollacco Don L., Wheatley Peter J., Grange Andrew, Jordán Andrés, Lawrie Katherine, McCormac James, Neveu Marion

Publikováno v: EPJ Web of Conferences, Vol 47, p 13002 (2013)

The Next Generation Transit Survey (NGTS) is a new ground-based sky survey designed to find transiting Neptunes and super-Earths. By covering at least sixteen times the sky area of Kepler, we will find small planets around stars that are sufficiently

Externí odkaz: https://doaj.org/article/4f3688579f5a43ab86ff2c7e88a1d655

Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer.

Autor: Cappellesso F; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Orban MP; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Shirgaonkar N; Laboratory of Precision Oncology and Cancer Evolution, Genome Institute of Singapore, A*STAR, Singapore, Singapore., Berardi E; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Serneels J; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Neveu MA; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Di Molfetta D; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Bari, Italy., Piccapane F; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Bari, Italy., Caroppo R; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Bari, Italy., Debellis L; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Bari, Italy., Ostyn T; Department of Imaging and Pathology, Translational Cell and Tissue Research, KU Leuven and University Hospitals Leuven, Leuven, Belgium., Joudiou N; Nuclear and Electron Spin Technologies Platform (NEST), Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium., Mignion L; Nuclear and Electron Spin Technologies Platform (NEST), Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium., Richiardone E; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérmentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium., Jordan BF; Nuclear and Electron Spin Technologies Platform (NEST), Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium., Gallez B; Nuclear and Electron Spin Technologies Platform (NEST), Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain, Brussels, Belgium., Corbet C; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérmentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium., Roskams T; Department of Imaging and Pathology, Translational Cell and Tissue Research, KU Leuven and University Hospitals Leuven, Leuven, Belgium., DasGupta R; Laboratory of Precision Oncology and Cancer Evolution, Genome Institute of Singapore, A*STAR, Singapore, Singapore., Tejpar S; Laboratory of Molecular Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium., Di Matteo M; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Taverna D; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Molecular Biotechnology Center, University of Torino, Torino, Italy., Reshkin SJ; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Bari, Italy., Topal B; Department of Abdominal Surgery, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium., Virga F; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Molecular Biotechnology Center, University of Torino, Torino, Italy., Mazzone M; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium. massimiliano.mazzone@kuleuven.vib.be.; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium. massimiliano.mazzone@kuleuven.vib.be.

Publikováno v: Nature cancer [Nat Cancer] 2022 Dec; Vol. 3 (12), pp. 1464-1483. Date of Electronic Publication: 2022 Dec 15.

Lactate Production Precedes Inflammatory Cell Recruitment in Arthritic Ankles: an Imaging Study.

Autor: Neveu MA; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Roentgenweg 13, 72076, Tuebingen, Germany., Beziere N; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Roentgenweg 13, 72076, Tuebingen, Germany., Daniels R; Department of Pharmaceutical Technology, Eberhard Karls University Tuebingen, Tuebingen, Germany., Bouzin C; IREC Imaging Platform, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium., Comment A; General Electric Healthcare, Pollards Wood, Nightingales Lane, Chalfont St Giles, UK., Schwenck J; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Roentgenweg 13, 72076, Tuebingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Fuchs K; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Roentgenweg 13, 72076, Tuebingen, Germany., Kneilling M; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Roentgenweg 13, 72076, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; Department of Dermatology, Eberhard Karls University Tuebingen, Tuebingen, Germany., Pichler BJ; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Roentgenweg 13, 72076, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Schmid AM; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Roentgenweg 13, 72076, Tuebingen, Germany. a.schmid@med.uni-tuebingen.de.

Publikováno v: Molecular imaging and biology [Mol Imaging Biol] 2020 Oct; Vol. 22 (5), pp. 1324-1332.

¹⁷ O MRS assesses the effect of mild hypothermia on oxygen consumption rate in tumors.

Autor: Neveu MA; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), Belgium., Joudiou N; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), Belgium., De Preter G; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), Belgium., Dehoux JP; Experimental Surgery Unit, Medical School, Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain (UCL), Belgium., Jordan BF; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), Belgium., Gallez B; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), Belgium.

Publikováno v: NMR in biomedicine [NMR Biomed] 2017 Aug; Vol. 30 (8). Date of Electronic Publication: 2017 Apr 21.

The Blood Flow Shutdown Induced by Combretastatin A4 Impairs Gemcitabine Delivery in a Mouse Hepatocarcinoma.

Autor: Fruytier AC; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université Catholique de Louvain Brussels, Belgium., Le Duff CS; Institute of Condensed Matter and Nanosciences, Université Catholique de Louvain Louvain-la-Neuve, Belgium., Po C; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université Catholique de Louvain Brussels, Belgium., Magat J; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université Catholique de Louvain Brussels, Belgium., Bouzin C; Institut de Recherche Expérimentale et Clinique, Pole of Pharmacology, Angiogenesis and Cancer Research Laboratory, Université Catholique de Louvain Brussels, Belgium., Neveu MA; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université Catholique de Louvain Brussels, Belgium., Feron O; Institut de Recherche Expérimentale et Clinique, Pole of Pharmacology, Angiogenesis and Cancer Research Laboratory, Université Catholique de Louvain Brussels, Belgium., Jordan BF; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université Catholique de Louvain Brussels, Belgium., Gallez B; Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université Catholique de Louvain Brussels, Belgium.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2016 Dec 23; Vol. 7, pp. 506. Date of Electronic Publication: 2016 Dec 23 (Print Publication: 2016).